Molecular characterization and antimicrobial susceptibility profiles in Streptococcus agalactiae colonizing strains: Association of erythromycin resistance with subtype III-1 genetic clone family

Clinical Microbiology and Infection

Volumn 16, Issue 9, 2010, Pages 1458-1463

  Florindo, C ^a   Viegas, S ^a   Paulino, A ^a   Rodrigues, E ^a   Gomes, J P ^a   Borrego, M J ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

Antibiotic resistance; Capsular genotyping; MLST; Portugal; Streptococcus agalactiae

Indexed keywords

BACTERIAL PROTEIN; CLINDAMYCIN; ERM METHYLTRANSFERASE; ERYTHROMYCIN; MACROLIDE; METHYLTRANSFERASE; PENICILLIN G; PROTEIN ERMB; PROTEIN ERMTR; PROTEIN MEFA; UNCLASSIFIED DRUG; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL MEMBRANE; BACTERIUM CARRIER; BACTERIUM ISOLATE; CONTROLLED STUDY; EPSILOMETER TEST; FEMALE; GENETIC SIMILARITY; GENOTYPE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PORTUGAL; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STREPTOCOCCUS AGALACTIAE;

STREPTOCOCCUS AGALACTIAE;

EID: 77956104971     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03106.x     Document Type: Article

References (30)

1. Schuchat A. Group B streptococcus. Lancet 1999, 353:51-56.
2. Brimil N, Barthell E, Heindrichs U, Kunh M, Lutticken R, Spellerberg B. Epidemiology of Streptococcus agalactiae colonization in Germany. Int J Med Microbiol 2006, 296:39-44.
3. Hansen SM, Uldbjerg N, Kilian M, Sorensen UB. Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. J Clin Microbiol 2004, 42:83-89.
4. Motlova J, Strakova L, Urbaskova P, Sak P, Sever T. Vaginal and rectal carriage of Streptococcus agalactiae in the Czech Republic: incidence, serotypes distribution and susceptibility to antibiotics. Indian J Med Res 2004, 119:84-87.
5. Yucesoy G, Caliskan E, Karadenizli A. Maternal colonisation with group B streptococcus and effectiveness of a culture-based protocol to prevent early-onset neonatal sepsis. Int J Clin Pract 2004, 58:735-739.
6. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. Morb Mortal Wkly Rep 2002, 51:1-22. Centers for Disease Control and Prevention
7. de Azavedo JC, McGavin M, Duncan C, Low DE, McGeer A. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 2001, 45:3504-3508.
8. Fitoussi F, Loukil C, Gros I. Mechanisms of macrolide resistance in clinical group B streptococci isolated in France. Antimicrob Agents Chemother 2001, 45:1889-1891.
9. Gygax SE, Schuyler JA, Kimmel LE, Trama JP, Mordechai E, Adelson ME. Erythromycin and clindamycin resistance in group B streptococcal clinical isolates. Antimicrob Agents Chemother 2006, 50:1875-1877.
10. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002, 34:482-492.
11. Hickman ME, Rench MA, Ferrieri P, Baker CJ. Changing epidemiology of group B streptococcal colonization. Pediatrics 1999, 104:203-209.
12. Jones N, Bohnsack JF, Takahashi S. Multilocus sequence typing system for group B streptococcus. J Clin Microbiol 2003, 41:2530-2536.
13. Performance standards for antimicrobial susceptibility testing 2009, Clinical and Laboratory Standards Institute, nineteenth informational supplement. CLSI document M02-A10, M07-A8, Wayne, PA, CLSI
14. Sutcliffe JA, Grebe T, Tait-Kamradt A, Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996, 40:2562-2566.
15. Kong F, Gowan S, Martin D, James G, Gilbert GL. Serotype identification of group B streptococci by PCR and sequencing. J Clin Microbiol 2002, 40:216-226.
16. Figueira-Coelho J, Ramirez M, Salgado MJ, Melo-Cristino J. Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates. Microb Drug Resist 2004, 10:31-36.
17. Neto NT. Group B streptococcal disease in Portuguese infants younger than 90 days. Arch Dis Child Fetal Neonatal Ed 2008, 93:F90-F93.
18. Martinho F, Prieto E, Pinto D. Evaluation of liquid biphasic granada medium and instant liquid biphasic granada medium for group B streptococcus detection. Enferm Infecc Microbiol Clin 2008, 26:69-71.
19. Håkansson S, Axemo P, Bremme K. Group B streptococcal carriage in Sweden: a national study on risk factors for mother and infant colonisation. Acta Obstet Gynecol Scand 2008, 87:50-58.
20. Tsolia M, Psoma M, Gavrili S. Group B streptococcus colonization of Greek pregnant women and neonates: prevalence, risk factors and serotypes. Clin Microbiol Infect 2003, 9:832-838.
21. Amin A, Abdulrazzaq YM, Uduman S. Group B streptococcal serotype distribution of isolates from colonized pregnant women at the time of delivery in United Arab Emirates. J Infect 2002, 45:42-46.
22. Lachenauer CS, Kasper DL, Shimada J. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis 1999, 179:1030-1033.
23. Dahesh S, Hensler ME, Van Sorge NM. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother 2008, 52:2915-2918.
24. Kimura K, Suzuki S, Wachino J. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 2008, 52:2890-2897.
25. Borchardt SM, DeBusscher JH, Tallman PA. Frequency of antimicrobial resistance among invasive and colonizing group B streptococcal isolates. BMC Infect Dis 2006, 6:57.
26. Bronzwaer SL, Cars O, Buchholz U. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002, 8:278-282.
27. Coenen S, Ferech M, Malhotra-Kumar S. European surveillance of antimicrobial consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. J Antimicrob Chemother 2006, 58:418.
28. Diner EJ, Hayes CS. Recombineering reveals a diverse collection of ribosomal proteins L4 and L22 that confer resistance to macrolide antibiotics. J Mol Biol 2009, 386:300-315.
29. Luna VA, Coates P, Eady EA, Cove JH, Nguyen TT, Roberts MC. A variety of gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother 1999, 44:19-25.
30. Manning SD, Schaeffer KE, Springman AC. Genetic diversity and antimicrobial resistance in group B streptococcus colonizing young, nonpregnant women. Clin Infect Dis 2008, 47:388-390.